Jenny Goudemand

9.4k total citations · 2 hit papers
167 papers, 4.9k citations indexed

About

Jenny Goudemand is a scholar working on Hematology, Genetics and Genetics. According to data from OpenAlex, Jenny Goudemand has authored 167 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 137 papers in Hematology, 33 papers in Genetics and 20 papers in Genetics. Recurrent topics in Jenny Goudemand's work include Platelet Disorders and Treatments (95 papers), Hemophilia Treatment and Research (56 papers) and Blood Coagulation and Thrombosis Mechanisms (39 papers). Jenny Goudemand is often cited by papers focused on Platelet Disorders and Treatments (95 papers), Hemophilia Treatment and Research (56 papers) and Blood Coagulation and Thrombosis Mechanisms (39 papers). Jenny Goudemand collaborates with scholars based in France, United Kingdom and Germany. Jenny Goudemand's co-authors include Claudine Caron, C Chopin, François Fourrier, P. Lestavel, Claudine Mazurier, Brigitte Jude, Sophie Susen, André Vincentelli, F Bauters and Thierry Le Tourneau and has published in prestigious journals such as New England Journal of Medicine, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Jenny Goudemand

159 papers receiving 4.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Acquired von Willebrand Syndrome in Aortic Stenosis

2003 557 citations Sophie Susen, Anne Bauters et al. profile →
Septic Shock, Multiple Organ Failure, and Disseminated Intravascular Coagulation

1992 527 citations François Fourrier, C Chopin et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jenny Goudemand France	36	3.5k	934	815	726	629	167	4.9k
PM Mannucci Italy	37	3.0k 0.9×	608 0.7×	701 0.9×	467 0.6×	648 1.0×	116	4.2k
W. Keith Hoots United States	34	2.5k 0.7×	574 0.6×	377 0.5×	586 0.8×	530 0.8×	97	4.2k
Paul Knöbl Austria	42	3.2k 0.9×	1.2k 1.3×	497 0.6×	509 0.7×	424 0.7×	159	5.6k
Jeanne M. Lusher United States	45	5.5k 1.6×	1.5k 1.6×	509 0.6×	216 0.3×	235 0.4×	173	6.9k
W. Kreuz Germany	39	3.0k 0.9×	1.7k 1.8×	347 0.4×	297 0.4×	217 0.3×	137	4.7k
Lorenzo Alberio Switzerland	30	1.8k 0.5×	456 0.5×	748 0.9×	389 0.5×	752 1.2×	169	3.8k
Terry Gernsheimer United States	28	4.3k 1.2×	887 0.9×	884 1.1×	168 0.2×	292 0.5×	89	5.6k
Abdulgabar Salama Germany	32	2.4k 0.7×	770 0.8×	474 0.6×	245 0.3×	204 0.3×	141	4.4k
Andreas Hillarp Sweden	33	2.6k 0.7×	592 0.6×	492 0.6×	167 0.2×	1.4k 2.2×	105	4.2k
Mark Weinstein United States	25	2.0k 0.6×	473 0.5×	741 0.9×	163 0.2×	405 0.6×	53	3.8k

Countries citing papers authored by Jenny Goudemand

Since Specialization

Citations

This map shows the geographic impact of Jenny Goudemand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jenny Goudemand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jenny Goudemand more than expected).

Fields of papers citing papers by Jenny Goudemand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jenny Goudemand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jenny Goudemand. The network helps show where Jenny Goudemand may publish in the future.

Co-authorship network of co-authors of Jenny Goudemand

This figure shows the co-authorship network connecting the top 25 collaborators of Jenny Goudemand. A scholar is included among the top collaborators of Jenny Goudemand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jenny Goudemand. Jenny Goudemand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Goudemand, Jenny & Sophie Susen. (2023). von Willebrand factor: aging is better?. Journal of Thrombosis and Haemostasis. 21(12). 3357–3359.

Laffan, Michael, et al.. (2022). The Cost of Von Willebrand Disease in Europe: The CVESS Study. Clinical and Applied Thrombosis/Hemostasis. 28. 2985302087–2985302087. 3 indexed citations

Peyron, Ivan, Serge Pierre‐Louis, Pierre Boisseau, et al.. (2022). Identification of von Willebrand factor D4 domain mutations in patients of Afro‐Caribbean descent: In vitro characterization. Research and Practice in Thrombosis and Haemostasis. 6(4). e12737–e12737. 2 indexed citations

Goudemand, Jenny, et al.. (2021). Costs and management of patients with hemophilia A in France: the Hemraude study. The European Journal of Health Economics. 23(1). 23–32. 6 indexed citations

Lassalle, Fanny, Loubna Jouan, Laura L. Swystun, et al.. (2020). The challenge of genetically unresolved haemophilia A patients: Interest of the combination of whole F8 gene sequencing and functional assays. Haemophilia. 26(6). 1056–1063. 11 indexed citations

Jong, Annika de, Richard Dirven, Lisa D.S. Bloomer, et al.. (2020). Characterization of large in-frame von Willebrand factor deletions highlights differing pathogenic mechanisms. Blood Advances. 4(13). 2979–2990. 7 indexed citations

Piérache, Adeline, Anne Bauters, Antoine Rauch, et al.. (2019). Hemostatic profile of infants with spontaneous prematurity: can we predict intraventricular hemorrhage development?. The Italian Journal of Pediatrics/Italian journal of pediatrics. 45(1). 113–113. 10 indexed citations

Susen, Sophie, Yves Gruel, Anne Godiér, et al.. (2019). Management of bleeding and invasive procedures in haemophilia A patients with inhibitor treated with emicizumab (Hemlibra^®): Proposals from the French network on inherited bleeding disorders (MHEMO), the French Reference Centre on Haemophilia, in collaboration with the French Working Group on Perioperative Haemostasis (GIHP). Haemophilia. 25(5). 731–737. 41 indexed citations

Goudemand, Jenny, Flora Peyvandi, & Sébastien Lacroix‐Desmazes. (2016). Key insights to understand the immunogenicity of FVIII products. Thrombosis and Haemostasis. 116(S 01). S2–S9. 7 indexed citations

10.

Calvez, Thierry, Hérvè Chambost, Ségolène Claeyssens‐Donadel, et al.. (2014). Recombinant factor VIII products and inhibitor development in previously untreated boys with severe hemophilia A. Blood. 124(23). 3398–3408. 108 indexed citations

11.

Eikenboom, Jeroen, Augusto B. Federici, Richard Dirven, et al.. (2013). VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease. Blood. 121(12). 2336–2339. 84 indexed citations

12.

Calvez, Thierry, Y. Laurian, & Jenny Goudemand. (2008). Inhibitor incidence with recombinant vs. plasma-derived FVIII in previously untreated patients with severe hemophilia A: homogeneous results from four published observational studies. Journal of Thrombosis and Haemostasis. 6(2). 390–392. 18 indexed citations

13.

Denis, Cécile V., Ton Lisman, Jeroen Eikenboom, et al.. (2006). Variations in glycosylation of von Willebrand factor with O-linked sialylated T antigen are associated with its plasma levels. Blood. 109(6). 2430–2437. 57 indexed citations

14.

Goudemand, Jenny. (2001). Les anticorps anti-facteur VIII chez l'hémophile. Hématologie. 7(3). 170–183. 2 indexed citations

15.

Jourdain, M., Odile Carrette, A. Tournoys, et al.. (1997). Effects of Inter- α -inhibitor in Experimental Endotoxic Shock and Disseminated Intravascular Coagulation. American Journal of Respiratory and Critical Care Medicine. 156(6). 1825–1833. 32 indexed citations

16.

Meyer, Sebastian, et al.. (1980). Erythrocyte Glyoxalase I and Esterase D Polymorphisms in Four French Populations. Human Heredity. 30(4). 232–236. 8 indexed citations

17.

Miled, Abdelhédi, et al.. (1979). [Monoclonal myelomatous IgA with antilipoprotein antibody activity of Ra specificity (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 21(2). 171–83. 1 indexed citations

18.

Bauters, F, et al.. (1978). [Specific ovarian localizations in acute leukemias (apropos of 3 cases)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 23(3). 151–7. 1 indexed citations

19.

Goudemand, Jenny & F Santoro. (1978). Recherche de complexes immuns circulants dans des affections comportant un processus d'hyperdestruction plaquettaire.. Pathologie Biologie. 26(7). 1 indexed citations

20.

Goudemand, Jenny, et al.. (1976). [Acute agranulocytosis induced by pyramidon or phenothiazines. Apropos of 31 cases].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 52(25-28). 1513–20. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact